194 related articles for article (PubMed ID: 36282572)
1. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
[TBL] [Abstract][Full Text] [Related]
2. First Report of FARSA in the Regulation of Cell Cycle and Survival in Mantle Cell Lymphoma Cells via PI3K-AKT and FOXO1-RAG1 Axes.
Feng M; Yang K; Wang J; Li G; Zhang H
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675119
[TBL] [Abstract][Full Text] [Related]
3. FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization.
Vasquez YM; Mazur EC; Li X; Kommagani R; Jiang L; Chen R; Lanz RB; Kovanci E; Gibbons WE; DeMayo FJ
Mol Endocrinol; 2015 Mar; 29(3):421-33. PubMed ID: 25584414
[TBL] [Abstract][Full Text] [Related]
4. Positive intergenic feedback circuitry, involving EBF1 and FOXO1, orchestrates B-cell fate.
Mansson R; Welinder E; Åhsberg J; Lin YC; Benner C; Glass CK; Lucas JS; Sigvardsson M; Murre C
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):21028-33. PubMed ID: 23213261
[TBL] [Abstract][Full Text] [Related]
5. FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression.
Tang Y; Jiang L; Zhao X; Hu D; Zhao G; Luo S; Du X; Tang W
Cell Biol Int; 2021 Dec; 45(12):2510-2520. PubMed ID: 34459063
[TBL] [Abstract][Full Text] [Related]
6. Genomic Binding Patterns of Forkhead Box Protein O1 Reveal Its Unique Role in Cardiac Hypertrophy.
Pfleger J; Coleman RC; Ibetti J; Roy R; Kyriazis ID; Gao E; Drosatos K; Koch WJ
Circulation; 2020 Sep; 142(9):882-898. PubMed ID: 32640834
[TBL] [Abstract][Full Text] [Related]
7. FOXO Dictates Initiation of B Cell Development and Myeloid Restriction in Common Lymphoid Progenitors.
Peña-Pérez L; Kharazi S; Frengen N; Krstic A; Bouderlique T; Hauenstein J; He M; Somuncular E; Li Wang X; Dahlberg C; Gustafsson C; Johansson AS; Walfridsson J; Kadri N; Woll P; Kierczak M; Qian H; Westerberg L; Luc S; Månsson R
Front Immunol; 2022; 13():880668. PubMed ID: 35603175
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928
[TBL] [Abstract][Full Text] [Related]
9. Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.
Queirós AC; Beekman R; Vilarrasa-Blasi R; Duran-Ferrer M; Clot G; Merkel A; Raineri E; Russiñol N; Castellano G; Beà S; Navarro A; Kulis M; Verdaguer-Dot N; Jares P; Enjuanes A; Calasanz MJ; Bergmann A; Vater I; Salaverría I; van de Werken HJG; Wilson WH; Datta A; Flicek P; Royo R; Martens J; Giné E; Lopez-Guillermo A; Stunnenberg HG; Klapper W; Pott C; Heath S; Gut IG; Siebert R; Campo E; Martín-Subero JI
Cancer Cell; 2016 Nov; 30(5):806-821. PubMed ID: 27846393
[TBL] [Abstract][Full Text] [Related]
10. PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma.
Zhang X; Han Y; Nie Y; Jiang Y; Sui X; Ge X; Liu F; Zhang Y; Wang X
J Mol Med (Berl); 2023 May; 101(5):595-606. PubMed ID: 37126184
[TBL] [Abstract][Full Text] [Related]
11. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
[TBL] [Abstract][Full Text] [Related]
12. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
Vegliante MC; Palomero J; Pérez-Galán P; Roué G; Castellano G; Navarro A; Clot G; Moros A; Suárez-Cisneros H; Beà S; Hernández L; Enjuanes A; Jares P; Villamor N; Colomer D; Martín-Subero JI; Campo E; Amador V
Blood; 2013 Mar; 121(12):2175-85. PubMed ID: 23321250
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Occupancy Profiling Reveals Critical Roles of FoxO1 in Regulating Extracellular Matrix and Circadian Rhythm Genes in Human Chondrocytes.
Duffy T; Bekki H; Lotz MK
Arthritis Rheumatol; 2020 Sep; 72(9):1514-1523. PubMed ID: 32281255
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis.
Roberto MP; Varano G; Vinas-Castells R; Holmes AB; Kumar R; Pasqualucci L; Farinha P; Scott DW; Dominguez-Sola D
Immunity; 2021 Aug; 54(8):1807-1824.e14. PubMed ID: 34380064
[TBL] [Abstract][Full Text] [Related]
15. Fra-2 regulates B cell development by enhancing IRF4 and Foxo1 transcription.
Ubieta K; Garcia M; Grötsch B; Uebe S; Weber GF; Stein M; Ekici A; Schett G; Mielenz D; Bozec A
J Exp Med; 2017 Jul; 214(7):2059-2071. PubMed ID: 28566276
[TBL] [Abstract][Full Text] [Related]
16. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Villalonga P; Fernández de Mattos S
Br J Haematol; 2012 Feb; 156(3):334-45. PubMed ID: 22107151
[TBL] [Abstract][Full Text] [Related]
17. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma.
Kuo PY; Leshchenko VV; Fazzari MJ; Perumal D; Gellen T; He T; Iqbal J; Baumgartner-Wennerholm S; Nygren L; Zhang F; Zhang W; Suh KS; Goy A; Yang DT; Chan WC; Kahl BS; Verma AK; Gascoyne RD; Kimby E; Sander B; Ye BH; Melnick AM; Parekh S
Oncogene; 2015 Mar; 34(10):1231-40. PubMed ID: 24681958
[TBL] [Abstract][Full Text] [Related]
18. Cis-Regulatory Evolution of Forkhead Box O1 (FOXO1), a Terminal Selector Gene for Decidual Stromal Cell Identity.
Park Y; Nnamani MC; Maziarz J; Wagner GP
Mol Biol Evol; 2016 Dec; 33(12):3161-3169. PubMed ID: 27634871
[TBL] [Abstract][Full Text] [Related]
19. FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas.
Szydlowski M; Kiliszek P; Sewastianik T; Jablonska E; Bialopiotrowicz E; Gorniak P; Polak A; Markowicz S; Nowak E; Grygorowicz MA; Prochorec-Sobieszek M; Szumera-Cieckiewicz A; Malenda A; Lech-Maranda E; Warzocha K; Juszczynski P
Blood; 2016 Feb; 127(6):739-48. PubMed ID: 26585955
[TBL] [Abstract][Full Text] [Related]
20. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate.
Lin YC; Jhunjhunwala S; Benner C; Heinz S; Welinder E; Mansson R; Sigvardsson M; Hagman J; Espinoza CA; Dutkowski J; Ideker T; Glass CK; Murre C
Nat Immunol; 2010 Jul; 11(7):635-43. PubMed ID: 20543837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
